More languages
More actions
mNo edit summary |
mNo edit summary |
||
Line 32: | Line 32: | ||
| footnotes = <ref name=10K>{{Citation|title-url=https://s28.q4cdn.com/781576035/files/doc_financials/2021/ar/PFE-2021-Form-10K-FINAL.pdf |title=Pfizer Inc. 2021 Form 10-K Annual Report |publisher=Pfizer Inc.}}</ref> | | footnotes = <ref name=10K>{{Citation|title-url=https://s28.q4cdn.com/781576035/files/doc_financials/2021/ar/PFE-2021-Form-10K-FINAL.pdf |title=Pfizer Inc. 2021 Form 10-K Annual Report |publisher=Pfizer Inc.}}</ref> | ||
}} | }} | ||
'''Pfizer Inc.''' is a global pharmaceutical corporation. | '''Pfizer Inc.''' is a global pharmaceutical corporation. | ||
Revision as of 00:24, 16 September 2022
Pfizer Inc. | |
---|---|
Industry |
|
Key people | Albert Bourla (CEO) |
Revenue | + $81.29 billion[1] |
Net income | + $21.98 billion[1] |
Website | |
pfizer.com | |
[1] |
Pfizer Inc. is a global pharmaceutical corporation.
Violations
Fraudulent Marketing
On September 2, 2009, Pfizer was sued for $2.3 billion by the U.S government for fraudulent marketing of multiple products.[2]
Pfizer bribed the U.S government for $1 billion to resolve allegations under the False Claims Act of illegal promotion of the drugs: Bextra, Geodon, Zyvox, and Lyrica; and illegal bribery of hospital to promote these drugs.[2]
References
- ↑ 1.0 1.1 1.2 Pfizer Inc. 2021 Form 10-K Annual Report. Pfizer Inc..
- ↑ 2.0 2.1 Office of Public Affairs - Department of Justice. Justice Department Announces Largest Health Care Fraud Settlement in Its History.